[引用][C] 缺血预适应在合并急性前壁心肌梗死的糖尿病患者中的临床研究

马彩云, 李瑞杰, 李莉, 宋丽芬 - 临床荟萃, 2007

Reporte de altos requerimientos de insulina en pacientes críticos pediátricos con COVID-19. Experiencia con monitoreo remoto continuo de glucosa

AG Krochik, M Prieto, C Martínez Mateu… - Revista de la …, 2021 - SciELO Argentina
Reporte de altos requerimientos de insulina en pacientes críticos pediátricos con COVID-19.
Experiencia con monitoreo remoto Page 1 70 CASOS CLÍNICOS Reporte de altos …

Diabetes and the heart: could the diabetic myocardium be protected by preconditioning?

V Vinokur, G Leibowitz, L Grinberg, R Eliashar… - Redox …, 2007 - Taylor & Francis
Both type 1 and type 2 diabetes (insulin-dependent and non-insulin dependent diabetes,
respectively) are associated with increased risk for microvascular and macrovascular …

Non insulin-dependent diabetes mellitus (type 2) secondary failure. Metformin-glibenclamide treatment

MT Guagnano, V Pace-Palitti… - International …, 2001 - journals.sagepub.com
The goal of sulphonylurea (S) treatment in Non-Insulin-Dependent Diabetes Mellitus
(NIDDM-type 2 diabetes) subjects should be to obtain a satisfactory glycaemic control …

[引用][C] 磺脲类药物对糖尿病合并冠心病warm—up 现象的对比观察

郑梅, 李立卓, 姜志安, 李丽宏, 冯燕光, 傅向华 - 中华医学杂志, 2017

[HTML][HTML] Electrocardiographic score: Application in exercise test for the assessment of ischemic preconditioning

A Uchida, P Moffa, W Hueb, LAM Cesar… - Arquivos Brasileiros …, 2010 - SciELO Brasil
FUNDAMENTO: O tempo para 1, 0 mm de depressão do segmento ST (T-1, 0 mm), adotado
para caracterizar o precondicionamento isquêmico (PCI) em testes ergométricos …

ПРЕПАРАТЫ СУЛЬФОНИЛМОЧЕВИНЫ И РИСК СЕРДЕЧНО-СОСУДИСТЫХ ОСЛОЖНЕНИЙ-МНОГО ШУМА ИЗ НИЧЕГО?

ЛВ Недосугова - Фарматека, 2010 - elibrary.ru
Сердечно-сосудистые осложнения-основная причина летальности при сахарном
диабете типа 2. Доказана важность жесткого гликемического контроля в …

Myocardial preconditioning in the experimental model: a new strategy to improve myocardial protection

ER Rosenkranz, J Feng, HL Li - Myocardial protection. Oxford …, 2004 - Wiley Online Library
Experimental myocardial preconditioning 231 min) reperfusion periods are used [1]. By
contrast, protection is substantially attenuated if the period of prolonged ischemia is delayed …

[PDF][PDF] A brief survey of clinically used various cardiovascular agents

M Asif - Perspectives, 2017 - scholar.archive.org
Nowadays cardiovascular diseases are major public health problem wordwide, in this
regards ischemic heart disease (IHD) or coronary heart disease is more common. The …

Protective effects as ischemic preconditioning of sasanquasaponin mediated by KATP channel in the intact rat hearts1

QR HUANG, C Shou-Yi, M HE… - Chinese Journal of …, 2003 - manu41.magtech.com.cn
AIM: To study protective effects as myocardial ischemic preconditioning of sasanquasaponin
(SQS) and its relationship with KATP channel. METHODS: The study adopted the model of …